Search results
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 18 hours agoProofPilot, the industry's premier platform for patient & site automation, guidance, and seamless execution, announces today its nomination as a finalist for the second consecutive year at the ...
Moderna Results Beat Estimates as Company Prepares for RSV Shot Launch
Barrons.com· 15 hours agoThe biotech company used revenue from its Covid-19 vaccine to finance other new products.Read the...
Moderna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall By Investing.com
Investing.com· 14 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...
Moderna (MRNA) Set to Announce Earnings on Thursday
ETF DAILY NEWS· 2 days agoModerna (NASDAQ:MRNA – Get Free Report) will be releasing its earnings data before the market opens on Thursday, May 2nd. Analysts expect Moderna to post ...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks· 4 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
Why Moderna Partnered with OpenAI
Analytics India Magazine· 4 days ago“People literally talk about how AI is going to cure diseases someday, and I think this is a very meaningful first step,” said CEO Sam Altman about...
These Stocks Are Moving the Most Today: Carvana, Fastly, Peloton, Wayfair, Qualcomm, Moderna,...
Barrons.com· 5 hours agoCarvana posts a surprise first-quarter profit, Fastly stock sinks after the company issues guidance...
Top Stock Movers Now: Moderna, Wayfair, Peloton Interactive, and More
Investopedia· 18 hours agoThe Dow, S&P 500, and Nasdaq all rose. Moderna (MRNA) shares advanced after the vaccine maker...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 6 hours agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,100 Today - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoModerna MRNA has outperformed the market over the past 5 years by 23.65% on an annualized basis producing an average annual return of 35.34%. Currently, Moderna< ...
